814 related articles for article (PubMed ID: 3262710)
21. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
Patel SS; Thiele DL; Lipsky PE
J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232
[TBL] [Abstract][Full Text] [Related]
22. Expansion of major histocompatibility complex-restricted antimelanoma cytotoxic T-cell lymphocyte clones with identical T-cell receptor from tumor-infiltrating lymphocytes.
Sensi M; Castelli C; Salvi S; Mazzocchi A; Mortarini R; Nicolini G; Anichini A; Parmiani G
J Immunother (1991); 1992 Oct; 12(3):207-11. PubMed ID: 1332745
[TBL] [Abstract][Full Text] [Related]
23. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
24. [Tumor-infiltrating lymphocytes from human metastatic melanoma].
Itoh K
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2119-26. PubMed ID: 3496855
[TBL] [Abstract][Full Text] [Related]
25. T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis.
Anichini A; Mortarini R; Alberti S; Mantovani A; Parmiani G
Int J Cancer; 1993 Apr; 53(6):994-1001. PubMed ID: 8097188
[TBL] [Abstract][Full Text] [Related]
26. Increased tumor-specific CTL activity in human tumor-infiltrating lymphocytes stimulated with autologous tumor lines.
Reilly EB; Antognetti G
Cell Immunol; 1991 Jul; 135(2):526-33. PubMed ID: 2036681
[TBL] [Abstract][Full Text] [Related]
27. In vitro expansion of tumor-specific, HLA-restricted human CD8+ cytolytic T lymphocytes.
Nakashima M; Watanabe T; Koprowski H; Schuchter L; Steplewski Z
Cell Immunol; 1994 Apr; 155(1):53-61. PubMed ID: 7513262
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.
Matsuda M; Salazar F; Petersson M; Masucci G; Hansson J; Pisa P; Zhang QJ; Masucci MG; Kiessling R
J Exp Med; 1994 Dec; 180(6):2371-6. PubMed ID: 7964510
[TBL] [Abstract][Full Text] [Related]
29. Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors.
Shimizu Y; Iwatsuki S; Herberman RB; Whiteside TL
Int J Cancer; 1990 Nov; 46(5):878-83. PubMed ID: 2146230
[TBL] [Abstract][Full Text] [Related]
30. Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.
Kan-Mitchell J; Huang XQ; Steinman L; Oksenberg JR; Harel W; Parker JW; Goedegebuure PS; Darrow TL; Mitchell MS
Cancer Immunol Immunother; 1993 Jul; 37(1):15-25. PubMed ID: 8513449
[TBL] [Abstract][Full Text] [Related]
31. Human autologous tumor-specific T cells in malignant melanoma.
Platsoucas CD
Cancer Metastasis Rev; 1991 Jun; 10(2):151-76. PubMed ID: 1873855
[TBL] [Abstract][Full Text] [Related]
32. High proliferative capacity and specific antiautologous melanoma cytotoxicity of a human T-lymphocyte clone derived from tumor-infiltrating lymphocytes.
Gervois N; Heuze F; Diez E; Jotereau F
Hum Immunol; 1990 Jun; 28(2):112-8. PubMed ID: 2141008
[TBL] [Abstract][Full Text] [Related]
33. Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines.
Dufour E; Carcelain G; Gaudin C; Flament C; Avril MF; Faure F
J Immunol; 1997 Apr; 158(8):3787-95. PubMed ID: 9103444
[TBL] [Abstract][Full Text] [Related]
34. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas.
Topalian SL; Solomon D; Rosenberg SA
J Immunol; 1989 May; 142(10):3714-25. PubMed ID: 2785562
[TBL] [Abstract][Full Text] [Related]
35. Solid-phase anti-CD3 antibody activation of murine tumor-infiltrating lymphocytes.
Massaro AF; Schoof DD; Rubinstein A; Zuber M; Leonard-Vidal FJ; Eberlein TJ
Cancer Res; 1990 May; 50(9):2587-92. PubMed ID: 2139356
[TBL] [Abstract][Full Text] [Related]
36. Role of uncultured human melanoma cells in the proliferation of autologous tumor-specific cytotoxic T lymphocytes.
Salmeron MA; Balch CM; Ross MI; Itoh K
Cell Immunol; 1992 Aug; 143(1):228-37. PubMed ID: 1623565
[TBL] [Abstract][Full Text] [Related]
37. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
Anichini A; Maccalli C; Mortarini R; Salvi S; Mazzocchi A; Squarcina P; Herlyn M; Parmiani G
J Exp Med; 1993 Apr; 177(4):989-98. PubMed ID: 8459226
[TBL] [Abstract][Full Text] [Related]
38. Tumor-infiltrating CD3- NK cells are more effective than CD3+ T cells in killing autologous melanoma cells.
Azogui O; Avril MF; Margulis A; Guillard M; Caillou B; Prade M
J Invest Dermatol; 1991 Sep; 97(3):425-9. PubMed ID: 1831465
[TBL] [Abstract][Full Text] [Related]
39. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
[TBL] [Abstract][Full Text] [Related]
40. Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix.
Santin AD; Bellone S; Palmieri M; Bossini B; Roman JJ; Cannon MJ; Bignotti E; Canè S; Pecorelli S
Gynecol Oncol; 2003 May; 89(2):271-80. PubMed ID: 12713991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
